Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBushveld Minerals Regulatory News (BMN)

  • This share is currently suspended. It was suspended at a price of 0.306
  • There is currently no data for BMN

Form 8.3 of the Takeover Code

2 Feb 2024 14:30

RNS Number : 9141B
Bushveld Minerals Limited
02 February 2024
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Bushveld Minerals Ltd

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Mustang Energy PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

01/02/2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

0.1p ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,880,366

 

15.46

Nill

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

1,880,366

 

15.46

Nill

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

warrants

Details, including nature of the rights concerned and relevant percentages:

636,986

exercise price: £0.30

grant date: 22/11/2023

expiry date: 15/11/2024

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

N/A

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

02/02/2024

Contact name:

Chika Edeh

Telephone number*:

 

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETEALAAEANLEFA
Date   Source Headline
16th May 20257:00 amRNSCancellation - Bushveld Minerals Limited
15th Apr 20254:28 pmRNSAppointment of Liquidators & Resignation of Nomad
11th Apr 20257:57 amRNSNotice of appointment of liquidators
15th Jan 20256:00 pmRNSBushveld Minerals
16th Dec 20247:15 amRNSBusiness Rescue and Operations Update
4th Dec 20247:00 amRNSResignation of Directors
29th Nov 20247:00 amRNSDefault on Shareholder Loan Repayment by Vanchem
19th Nov 202410:01 amRNSAppointment of Business Rescue Practitioners
18th Nov 20247:30 amRNSSuspension - Bushveld Minerals Limited
18th Nov 20247:00 amRNSTrading Suspension
8th Nov 20249:25 amRNSQ3 and 9M 2024 Operational Update
1st Nov 20243:05 pmRNSVanchem Sale Update
25th Oct 20242:21 pmRNSOperational Update
18th Oct 20249:18 amRNSDisposal of Interests in Lemur Holdings Limited
17th Sep 20247:00 amRNSInterim Results for Six Months ended 30 June 2024
10th Sep 20247:00 amRNSTurnaround Initiatives Underway
2nd Sep 20244:22 pmRNSOrion Matched Funding Received
14th Aug 20246:00 pmRNSSARB Approval for Orion US$10M Matched Funding
12th Aug 20244:13 pmRNSUS$2 million SPR Debt Funding Received
9th Aug 20249:55 amRNSAgreement re Settlement of SPR Subscription Funds
7th Aug 20244:25 pmRNSAnnual General Meeting Results
7th Aug 20247:00 amRNSDirector/PDMR Shareholding
6th Aug 20247:00 amRNSAnnual General Meeting Statement
31st Jul 20247:00 amRNSQ2 and H1 2024 Operational Update
24th Jul 20244:46 pmRNSHolding(s) in Company - Correction
15th Jul 202412:39 pmRNSDirector/PDMR Shareholding
12th Jul 20244:57 pmRNSDirector/PDMR Shareholding
11th Jul 20245:04 pmRNSPosting of Accounts & Notice of General Meeting
28th Jun 20245:30 pmRNSFinal Results for Year Ended 31 December 2023
28th Jun 20243:29 pmRNSFinancing Update: Orion matched funding of US$10m
28th Jun 20241:17 pmRNSHolding(s) in Company
26th Jun 202412:13 pmRNSHolding(s) in Company
24th Jun 20241:50 pmRNSSPR Funding & Orion 2024 Financing Package Update
31st May 20244:07 pmRNSCCSA Approval for sale of 64% interest in Mokopane
31st May 20241:07 pmRNSResult of Meeting
24th May 20245:53 pmRNSShareholder Correspondence and Questions & Answers
13th May 20247:00 amRNSPosting of Circular and Notice of General Meeting
7th May 20247:00 amRNSProposed conditional disposal of Vanchem
23rd Apr 20247:01 amRNSQ1 2024 Operational & Corporate Update
23rd Apr 20247:00 amRNSMineral Resources and Reserves Annual Update
14th Mar 20249:32 amRNSFurther Update on Outstanding Funds
14th Mar 20247:00 amRNSTR-1 Notification of Major Holdings
7th Mar 20243:00 pmRNSTR-1 Notification of Major Holdings
29th Feb 20245:30 pmRNSFurther Update on Outstanding Funds
16th Feb 20247:08 amRNSFurther update on Outstanding Funds
5th Feb 20247:08 amRNSFull year 2023 Operational Update
2nd Feb 20242:30 pmRNSForm 8.3 of the Takeover Code
1st Feb 20247:00 amRNSCompletion of Convertible Loan Note Refinancing
29th Jan 20244:25 pmRNSResignation of Finance Director
19th Jan 20244:32 pmRNSFurther Update on Outstanding Funds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.